Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.

Chuntova P, Chow F, Watchmaker PB, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, Heath JR, Lim M, Margolin KA, Chiocca EA, Kasahara N, Ellingson BM, Brown CE, Chen Y, Fecci PE, Reardon DA, Dunn GP, Liau LM, Costello JF, Wick W, Cloughesy T, Timmer WC, Wen PY, Prins RM, Platten M, Okada H

Open source

DOI: 10.1093/neuonc/noaa277
Published: 2021 Mar 25
Container: Neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noaa277,
  title = {Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.},
  author = {Chuntova P and Chow F and Watchmaker PB and Galvez M and Heimberger AB and Newell EW and Diaz A and DePinho RA and Li MO and Wherry EJ and Mitchell D and Terabe M and Wainwright DA and Berzofsky JA and Herold-Mende C and Heath JR and Lim M and Margolin KA and Chiocca EA and Kasahara N and Ellingson BM and Brown CE and Chen Y and Fecci PE and Reardon DA and Dunn GP and Liau LM and Costello JF and Wick W and Cloughesy T and Timmer WC and Wen PY and Prins RM and Platten M and Okada H},
  year = {2021},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noaa277},
  url = {https://doi.org/10.1093/neuonc/noaa277}
}

RIS

TY  - JOUR
TI  - Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
AU  - Chuntova P
AU  - Chow F
AU  - Watchmaker PB
AU  - Galvez M
AU  - Heimberger AB
AU  - Newell EW
AU  - Diaz A
AU  - DePinho RA
AU  - Li MO
AU  - Wherry EJ
AU  - Mitchell D
AU  - Terabe M
AU  - Wainwright DA
AU  - Berzofsky JA
AU  - Herold-Mende C
AU  - Heath JR
AU  - Lim M
AU  - Margolin KA
AU  - Chiocca EA
AU  - Kasahara N
AU  - Ellingson BM
AU  - Brown CE
AU  - Chen Y
AU  - Fecci PE
AU  - Reardon DA
AU  - Dunn GP
AU  - Liau LM
AU  - Costello JF
AU  - Wick W
AU  - Cloughesy T
AU  - Timmer WC
AU  - Wen PY
AU  - Prins RM
AU  - Platten M
AU  - Okada H
PY  - 2021
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noaa277
UR  - https://doi.org/10.1093/neuonc/noaa277
ER  -

APA

P, C., F, C., PB, W., M, G., AB, H., EW, N., A, D., RA, D., MO, L., EJ, W., D, M., M, T., DA, W., JA, B., C, H., JR, H., M, L., KA, M., EA, C., N, K., BM, E., CE, B., Y, C., PE, F., DA, R., GP, D., LM, L., JF, C., W, W., T, C., WC, T., PY, W., RM, P., M, P., & H, O. (2021). Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.. Neuro-oncology. https://doi.org/10.1093/neuonc/noaa277

Source records

pubmed · retrieved 2026-09-27T11:56:18.826Z